Dyne Therapeutics
The Director, Clinical Scientist leads scientific and clinical development efforts for Dyne Therapeutics' rare neuromuscular disease programs. This role partners with the Clinical Development Lead and cross‑functional teams to design, execute, interpret, and communicate clinical studies, translating data into actionable insights for strategy, regulatory interactions, and external communications. The position also provides mentorship, ensures data quality, and supports safety oversight across global trials.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
Dyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for genetically driven neuromuscular diseases. Leveraging its proprietary FORCE™ platform, Dyne aims to address the root cause of disease and deliver functional improvement for people living with conditions such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD). The company advances a pipeline of therapeutics from discovery through clinical development with the mission of transforming the lives of patients with rare neuromuscular diseases.
Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)
2 days ago
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
3 days ago
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
22 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dyne Therapeutics.
15% above the average for this role
150-patient Dyne trial focuses on myotonic dystrophy daily function
3 days ago
Executive Director/Vice President, Medical Affairs – Genetic Rare Disease
Relay Therapeutics
Sr. Medical Science Liaison (MSL)
UCB
Medical Science Liaison
Protara Therapeutics
Senior Director, Clinical Development/Clinical Scientist
Replimune
Senior Medical Science Liaison (Central) - Rare Disease
Zevra
Senior Manager, Clinical Scientist
Korro Bio